LTB and neoplasm: Our findings also implicate the TNF pathway in CRCLM associated neutrophil populations, as well as LTB, complement system and antigen presentation pathways in CD4+ T cells from the same tissue, highlighting the potential of harnessing these aspects of the tumor microenvironment to selectively activate neutrophils for immunotherapy (7).